Abstract
GlaxoSmithKline is developing cilomilast, a phosphodiesterase 4 inhibitor, for the potential treatment of chronic obstructive pulmonary disease. The compound has been assessed in phase III clinical trials.
MeSH terms
-
Animals
-
Carboxylic Acids / pharmacology
-
Carboxylic Acids / therapeutic use
-
Cyclohexanecarboxylic Acids
-
Drug Industry / organization & administration
-
Humans
-
Meta-Analysis as Topic
-
Nitriles / pharmacology*
-
Nitriles / therapeutic use*
-
Pulmonary Disease, Chronic Obstructive / drug therapy
Substances
-
Carboxylic Acids
-
Cyclohexanecarboxylic Acids
-
Nitriles
-
Cilomilast